Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,797
archived clinical trials in
Peripheral Vascular Disease

HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated:  1/30/2018
Clinical Research Facility
mi
from
Glendale, CA
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated: 1/30/2018
Clinical Research Facility
mi
from
Glendale, CA
Click here to add this to my saved trials
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated:  1/30/2018
Clinical Research Facility
mi
from
Chicago, IL
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated: 1/30/2018
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated:  1/30/2018
Clinical Research Facility
mi
from
Kansas City, MO
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated: 1/30/2018
Clinical Research Facility
mi
from
Kansas City, MO
Click here to add this to my saved trials
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated:  1/30/2018
Clinical Research Facility
mi
from
West Orange, NJ
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated: 1/30/2018
Clinical Research Facility
mi
from
West Orange, NJ
Click here to add this to my saved trials
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated:  1/30/2018
Clinical Research Facility
mi
from
New York, NY
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated: 1/30/2018
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated:  1/30/2018
Clinical Research Facility
mi
from
New York, NY
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated: 1/30/2018
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated:  1/30/2018
Clinical Research Facility
mi
from
White Plains, NY
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated: 1/30/2018
Clinical Research Facility
mi
from
White Plains, NY
Click here to add this to my saved trials
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated:  1/30/2018
Clinical Research Facility
mi
from
Charlotte, NC
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated: 1/30/2018
Clinical Research Facility
mi
from
Charlotte, NC
Click here to add this to my saved trials
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated:  1/30/2018
Clinical Research Facility
mi
from
Portland, OR
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated: 1/30/2018
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated:  1/30/2018
Clinical Research Facility
mi
from
Houston, TX
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated: 1/30/2018
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated:  1/30/2018
Clinical Research Facility
mi
from
Scottsdale, AZ
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated: 1/30/2018
Clinical Research Facility
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated:  1/30/2018
Clinical Research Facility
mi
from
Phoenix, AZ
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated: 1/30/2018
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated:  1/30/2018
Clinical Research Facility
mi
from
Loma Linda, CA
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated: 1/30/2018
Clinical Research Facility
mi
from
Loma Linda, CA
Click here to add this to my saved trials
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated:  1/30/2018
Clinical Research Facility
mi
from
Orlando, FL
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated: 1/30/2018
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated:  1/30/2018
Clinical Research Facility
mi
from
Grand Rapids, MI
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated: 1/30/2018
Clinical Research Facility
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated:  1/30/2018
Clinical Research Facility
mi
from
Tulsa, OK
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated: 1/30/2018
Clinical Research Facility
mi
from
Tulsa, OK
Click here to add this to my saved trials
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated:  1/30/2018
mi
from
Elkins Park, PA
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated: 1/30/2018
mi
from
Elkins Park, PA
Click here to add this to my saved trials
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated:  1/30/2018
Clinical Research Facility
mi
from
Dallas, TX
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated: 1/30/2018
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
AngioDefender Versus Brachial Artery Ultrasound Imaging
Vascular Reactivity Assessment by a Novel Diagnostic Device, ANGIODEFENDER, Compared to Using Brachial Artery Ultrasound Imaging
Status: Enrolling
Updated:  1/31/2018
University of Colorado, Boulder
mi
from
Boulder, CO
AngioDefender Versus Brachial Artery Ultrasound Imaging
Vascular Reactivity Assessment by a Novel Diagnostic Device, ANGIODEFENDER, Compared to Using Brachial Artery Ultrasound Imaging
Status: Enrolling
Updated: 1/31/2018
University of Colorado, Boulder
mi
from
Boulder, CO
Click here to add this to my saved trials
AngioDefender Versus Brachial Artery Ultrasound Imaging
Vascular Reactivity Assessment by a Novel Diagnostic Device, ANGIODEFENDER, Compared to Using Brachial Artery Ultrasound Imaging
Status: Enrolling
Updated:  1/31/2018
Yale University Prevention Research Center
mi
from
Derby, CT
AngioDefender Versus Brachial Artery Ultrasound Imaging
Vascular Reactivity Assessment by a Novel Diagnostic Device, ANGIODEFENDER, Compared to Using Brachial Artery Ultrasound Imaging
Status: Enrolling
Updated: 1/31/2018
Yale University Prevention Research Center
mi
from
Derby, CT
Click here to add this to my saved trials
AngioDefender Versus Brachial Artery Ultrasound Imaging
Vascular Reactivity Assessment by a Novel Diagnostic Device, ANGIODEFENDER, Compared to Using Brachial Artery Ultrasound Imaging
Status: Enrolling
Updated:  1/31/2018
Medical College of Wisconsin
mi
from
Milwaukee, WI
AngioDefender Versus Brachial Artery Ultrasound Imaging
Vascular Reactivity Assessment by a Novel Diagnostic Device, ANGIODEFENDER, Compared to Using Brachial Artery Ultrasound Imaging
Status: Enrolling
Updated: 1/31/2018
Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
AngioDefender Versus Brachial Artery Ultrasound Imaging
Vascular Reactivity Assessment by a Novel Diagnostic Device, ANGIODEFENDER, Compared to Using Brachial Artery Ultrasound Imaging
Status: Enrolling
Updated:  1/31/2018
Boston University
mi
from
Boston, MA
AngioDefender Versus Brachial Artery Ultrasound Imaging
Vascular Reactivity Assessment by a Novel Diagnostic Device, ANGIODEFENDER, Compared to Using Brachial Artery Ultrasound Imaging
Status: Enrolling
Updated: 1/31/2018
Boston University
mi
from
Boston, MA
Click here to add this to my saved trials
AngioDefender Versus Brachial Artery Ultrasound Imaging
Vascular Reactivity Assessment by a Novel Diagnostic Device, ANGIODEFENDER, Compared to Using Brachial Artery Ultrasound Imaging
Status: Enrolling
Updated:  1/31/2018
University of Western Ontario
mi
from
London,
AngioDefender Versus Brachial Artery Ultrasound Imaging
Vascular Reactivity Assessment by a Novel Diagnostic Device, ANGIODEFENDER, Compared to Using Brachial Artery Ultrasound Imaging
Status: Enrolling
Updated: 1/31/2018
University of Western Ontario
mi
from
London,
Click here to add this to my saved trials
Pharmacogenomics of Anti-platelet Intervention-2 (PAPI-2) Study
Pharmacogenomics of Anti-platelet Intervention-2 (PAPI-2) Study: A Prospective, Multicenter, Randomized Trial of Genotype-directed (G-D)Versus Standard of Care (SOC)Anti-platelet Therapy
Status: Enrolling
Updated:  2/1/2018
University of Maryland School of Medicine
mi
from
Baltimore, MD
Pharmacogenomics of Anti-platelet Intervention-2 (PAPI-2) Study
Pharmacogenomics of Anti-platelet Intervention-2 (PAPI-2) Study: A Prospective, Multicenter, Randomized Trial of Genotype-directed (G-D)Versus Standard of Care (SOC)Anti-platelet Therapy
Status: Enrolling
Updated: 2/1/2018
University of Maryland School of Medicine
mi
from
Baltimore, MD
Click here to add this to my saved trials
Pharmacogenomics of Anti-platelet Intervention-2 (PAPI-2) Study
Pharmacogenomics of Anti-platelet Intervention-2 (PAPI-2) Study: A Prospective, Multicenter, Randomized Trial of Genotype-directed (G-D)Versus Standard of Care (SOC)Anti-platelet Therapy
Status: Enrolling
Updated:  2/1/2018
Sinai Center for Thrombosis Research
mi
from
Baltimore, MD
Pharmacogenomics of Anti-platelet Intervention-2 (PAPI-2) Study
Pharmacogenomics of Anti-platelet Intervention-2 (PAPI-2) Study: A Prospective, Multicenter, Randomized Trial of Genotype-directed (G-D)Versus Standard of Care (SOC)Anti-platelet Therapy
Status: Enrolling
Updated: 2/1/2018
Sinai Center for Thrombosis Research
mi
from
Baltimore, MD
Click here to add this to my saved trials
Pharmacogenomics of Anti-platelet Intervention-2 (PAPI-2) Study
Pharmacogenomics of Anti-platelet Intervention-2 (PAPI-2) Study: A Prospective, Multicenter, Randomized Trial of Genotype-directed (G-D)Versus Standard of Care (SOC)Anti-platelet Therapy
Status: Enrolling
Updated:  2/1/2018
Christiana Care Health System
mi
from
Newark, DE
Pharmacogenomics of Anti-platelet Intervention-2 (PAPI-2) Study
Pharmacogenomics of Anti-platelet Intervention-2 (PAPI-2) Study: A Prospective, Multicenter, Randomized Trial of Genotype-directed (G-D)Versus Standard of Care (SOC)Anti-platelet Therapy
Status: Enrolling
Updated: 2/1/2018
Christiana Care Health System
mi
from
Newark, DE
Click here to add this to my saved trials
Pharmacogenomics of Anti-platelet Intervention-2 (PAPI-2) Study
Pharmacogenomics of Anti-platelet Intervention-2 (PAPI-2) Study: A Prospective, Multicenter, Randomized Trial of Genotype-directed (G-D)Versus Standard of Care (SOC)Anti-platelet Therapy
Status: Enrolling
Updated:  2/1/2018
Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
Pharmacogenomics of Anti-platelet Intervention-2 (PAPI-2) Study
Pharmacogenomics of Anti-platelet Intervention-2 (PAPI-2) Study: A Prospective, Multicenter, Randomized Trial of Genotype-directed (G-D)Versus Standard of Care (SOC)Anti-platelet Therapy
Status: Enrolling
Updated: 2/1/2018
Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
Click here to add this to my saved trials
Pharmacogenomics of Anti-platelet Intervention-2 (PAPI-2) Study
Pharmacogenomics of Anti-platelet Intervention-2 (PAPI-2) Study: A Prospective, Multicenter, Randomized Trial of Genotype-directed (G-D)Versus Standard of Care (SOC)Anti-platelet Therapy
Status: Enrolling
Updated:  2/1/2018
Geisinger Health System
mi
from
Danville, PA
Pharmacogenomics of Anti-platelet Intervention-2 (PAPI-2) Study
Pharmacogenomics of Anti-platelet Intervention-2 (PAPI-2) Study: A Prospective, Multicenter, Randomized Trial of Genotype-directed (G-D)Versus Standard of Care (SOC)Anti-platelet Therapy
Status: Enrolling
Updated: 2/1/2018
Geisinger Health System
mi
from
Danville, PA
Click here to add this to my saved trials
Patient-centered Research Into Outcomes Stroke Patients Prefer and Effectiveness Research
Observational Study of Patient-centered Research Into Outcomes Stroke Patients Prefer and Effectiveness Research
Status: Enrolling
Updated:  2/1/2018
Duke Clinical Research Institute
mi
from
Durham, NC
Patient-centered Research Into Outcomes Stroke Patients Prefer and Effectiveness Research
Observational Study of Patient-centered Research Into Outcomes Stroke Patients Prefer and Effectiveness Research
Status: Enrolling
Updated: 2/1/2018
Duke Clinical Research Institute
mi
from
Durham, NC
Click here to add this to my saved trials
Combination Therapy Compared With Single-Drug Therapy in Patients With Cardiac Diseases
Thalassemia Clinical Research Network - Cardiac L1/DFO Trial
Status: Enrolling
Updated:  2/1/2018
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Combination Therapy Compared With Single-Drug Therapy in Patients With Cardiac Diseases
Thalassemia Clinical Research Network - Cardiac L1/DFO Trial
Status: Enrolling
Updated: 2/1/2018
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Combination Therapy Compared With Single-Drug Therapy in Patients With Cardiac Diseases
Thalassemia Clinical Research Network - Cardiac L1/DFO Trial
Status: Enrolling
Updated:  2/1/2018
Children's Hospital
mi
from
Oakland, CA
Combination Therapy Compared With Single-Drug Therapy in Patients With Cardiac Diseases
Thalassemia Clinical Research Network - Cardiac L1/DFO Trial
Status: Enrolling
Updated: 2/1/2018
Children's Hospital
mi
from
Oakland, CA
Click here to add this to my saved trials
Combination Therapy Compared With Single-Drug Therapy in Patients With Cardiac Diseases
Thalassemia Clinical Research Network - Cardiac L1/DFO Trial
Status: Enrolling
Updated:  2/1/2018
Children's Memorial Hospital
mi
from
Chicago, IL
Combination Therapy Compared With Single-Drug Therapy in Patients With Cardiac Diseases
Thalassemia Clinical Research Network - Cardiac L1/DFO Trial
Status: Enrolling
Updated: 2/1/2018
Children's Memorial Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
Combination Therapy Compared With Single-Drug Therapy in Patients With Cardiac Diseases
Thalassemia Clinical Research Network - Cardiac L1/DFO Trial
Status: Enrolling
Updated:  2/1/2018
Children's Hospital
mi
from
Boston, MA
Combination Therapy Compared With Single-Drug Therapy in Patients With Cardiac Diseases
Thalassemia Clinical Research Network - Cardiac L1/DFO Trial
Status: Enrolling
Updated: 2/1/2018
Children's Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Combination Therapy Compared With Single-Drug Therapy in Patients With Cardiac Diseases
Thalassemia Clinical Research Network - Cardiac L1/DFO Trial
Status: Enrolling
Updated:  2/1/2018
Weill Medical College of Cornell University
mi
from
New York, NY
Combination Therapy Compared With Single-Drug Therapy in Patients With Cardiac Diseases
Thalassemia Clinical Research Network - Cardiac L1/DFO Trial
Status: Enrolling
Updated: 2/1/2018
Weill Medical College of Cornell University
mi
from
New York, NY
Click here to add this to my saved trials
Combination Therapy Compared With Single-Drug Therapy in Patients With Cardiac Diseases
Thalassemia Clinical Research Network - Cardiac L1/DFO Trial
Status: Enrolling
Updated:  2/1/2018
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Combination Therapy Compared With Single-Drug Therapy in Patients With Cardiac Diseases
Thalassemia Clinical Research Network - Cardiac L1/DFO Trial
Status: Enrolling
Updated: 2/1/2018
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Comparative Effectiveness of Rehabilitation Services for Survivors of Acute Ischemic Stroke
Comparative Effectiveness of Rehabilitation Services for Survivors of Acute Ischemic Stroke
Status: Enrolling
Updated:  2/1/2018
Duke Univ Med Ctr
mi
from
Durham, NC
Comparative Effectiveness of Rehabilitation Services for Survivors of Acute Ischemic Stroke
Comparative Effectiveness of Rehabilitation Services for Survivors of Acute Ischemic Stroke
Status: Enrolling
Updated: 2/1/2018
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Cangrelor to Clopidogrel or Prasugrel Transition Study
A Study of the Transition From Cangrelor to Clopidogrel or Prasugrel in Patients With Coronary Artery Disease.
Status: Enrolling
Updated:  2/4/2018
Fletcher Allen Health Care
mi
from
Burlington, VT
Cangrelor to Clopidogrel or Prasugrel Transition Study
A Study of the Transition From Cangrelor to Clopidogrel or Prasugrel in Patients With Coronary Artery Disease.
Status: Enrolling
Updated: 2/4/2018
Fletcher Allen Health Care
mi
from
Burlington, VT
Click here to add this to my saved trials
DURABILITY™ Iliac Study
Protege® EverFlex™ and GPS™ Self-Expanding Iliac Study (DURABILITY™ Iliac)
Status: Enrolling
Updated:  2/5/2018
Mount Sinai School of Medicine
mi
from
New York, NY
DURABILITY™ Iliac Study
Protege® EverFlex™ and GPS™ Self-Expanding Iliac Study (DURABILITY™ Iliac)
Status: Enrolling
Updated: 2/5/2018
Mount Sinai School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
VISIBILITY™ Iliac Study
Visi-Pro™ Balloon Expandable Iliac Study (VISIBILITY™ Iliac)
Status: Enrolling
Updated:  2/5/2018
Holy Name Medical Center
mi
from
Teaneck, NJ
VISIBILITY™ Iliac Study
Visi-Pro™ Balloon Expandable Iliac Study (VISIBILITY™ Iliac)
Status: Enrolling
Updated: 2/5/2018
Holy Name Medical Center
mi
from
Teaneck, NJ
Click here to add this to my saved trials
Framingham State Food Study
Dietary Composition and Energy Expenditure During Weight-Loss Maintenance
Status: Enrolling
Updated:  2/6/2018
Framingham State University
mi
from
Framingham, MA
Framingham State Food Study
Dietary Composition and Energy Expenditure During Weight-Loss Maintenance
Status: Enrolling
Updated: 2/6/2018
Framingham State University
mi
from
Framingham, MA
Click here to add this to my saved trials
Carotid Plaque Characteristics by MRI in AIM-HIGH (Carotid MRI Substudy)
Carotid Plaque Characteristics by MRI in AIM-HIGH
Status: Enrolling
Updated:  2/7/2018
Cardiovascular Consultants, Ltd.
mi
from
Phoenix, AZ
Carotid Plaque Characteristics by MRI in AIM-HIGH (Carotid MRI Substudy)
Carotid Plaque Characteristics by MRI in AIM-HIGH
Status: Enrolling
Updated: 2/7/2018
Cardiovascular Consultants, Ltd.
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Carotid Plaque Characteristics by MRI in AIM-HIGH (Carotid MRI Substudy)
Carotid Plaque Characteristics by MRI in AIM-HIGH
Status: Enrolling
Updated:  2/7/2018
Long Beach VA Medical Center
mi
from
Long Beach, CA
Carotid Plaque Characteristics by MRI in AIM-HIGH (Carotid MRI Substudy)
Carotid Plaque Characteristics by MRI in AIM-HIGH
Status: Enrolling
Updated: 2/7/2018
Long Beach VA Medical Center
mi
from
Long Beach, CA
Click here to add this to my saved trials
Carotid Plaque Characteristics by MRI in AIM-HIGH (Carotid MRI Substudy)
Carotid Plaque Characteristics by MRI in AIM-HIGH
Status: Enrolling
Updated:  2/7/2018
University of Southern California
mi
from
Los Angeles, CA
Carotid Plaque Characteristics by MRI in AIM-HIGH (Carotid MRI Substudy)
Carotid Plaque Characteristics by MRI in AIM-HIGH
Status: Enrolling
Updated: 2/7/2018
University of Southern California
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Carotid Plaque Characteristics by MRI in AIM-HIGH (Carotid MRI Substudy)
Carotid Plaque Characteristics by MRI in AIM-HIGH
Status: Enrolling
Updated:  2/7/2018
University of Maryland
mi
from
Baltimore, MD
Carotid Plaque Characteristics by MRI in AIM-HIGH (Carotid MRI Substudy)
Carotid Plaque Characteristics by MRI in AIM-HIGH
Status: Enrolling
Updated: 2/7/2018
University of Maryland
mi
from
Baltimore, MD
Click here to add this to my saved trials
Carotid Plaque Characteristics by MRI in AIM-HIGH (Carotid MRI Substudy)
Carotid Plaque Characteristics by MRI in AIM-HIGH
Status: Enrolling
Updated:  2/7/2018
Johns Hopkins University
mi
from
Baltimore, MD
Carotid Plaque Characteristics by MRI in AIM-HIGH (Carotid MRI Substudy)
Carotid Plaque Characteristics by MRI in AIM-HIGH
Status: Enrolling
Updated: 2/7/2018
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Carotid Plaque Characteristics by MRI in AIM-HIGH (Carotid MRI Substudy)
Carotid Plaque Characteristics by MRI in AIM-HIGH
Status: Enrolling
Updated:  2/7/2018
The Mayo Clinic
mi
from
Rochester, MN
Carotid Plaque Characteristics by MRI in AIM-HIGH (Carotid MRI Substudy)
Carotid Plaque Characteristics by MRI in AIM-HIGH
Status: Enrolling
Updated: 2/7/2018
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Carotid Plaque Characteristics by MRI in AIM-HIGH (Carotid MRI Substudy)
Carotid Plaque Characteristics by MRI in AIM-HIGH
Status: Enrolling
Updated:  2/7/2018
Duke University
mi
from
Durham, NC
Carotid Plaque Characteristics by MRI in AIM-HIGH (Carotid MRI Substudy)
Carotid Plaque Characteristics by MRI in AIM-HIGH
Status: Enrolling
Updated: 2/7/2018
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
Carotid Plaque Characteristics by MRI in AIM-HIGH (Carotid MRI Substudy)
Carotid Plaque Characteristics by MRI in AIM-HIGH
Status: Enrolling
Updated:  2/7/2018
Wake Forest University
mi
from
Winston-Salem, NC
Carotid Plaque Characteristics by MRI in AIM-HIGH (Carotid MRI Substudy)
Carotid Plaque Characteristics by MRI in AIM-HIGH
Status: Enrolling
Updated: 2/7/2018
Wake Forest University
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Carotid Plaque Characteristics by MRI in AIM-HIGH (Carotid MRI Substudy)
Carotid Plaque Characteristics by MRI in AIM-HIGH
Status: Enrolling
Updated:  2/7/2018
Philadelphia VA Medical Center
mi
from
Philadelphia, PA
Carotid Plaque Characteristics by MRI in AIM-HIGH (Carotid MRI Substudy)
Carotid Plaque Characteristics by MRI in AIM-HIGH
Status: Enrolling
Updated: 2/7/2018
Philadelphia VA Medical Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Carotid Plaque Characteristics by MRI in AIM-HIGH (Carotid MRI Substudy)
Carotid Plaque Characteristics by MRI in AIM-HIGH
Status: Enrolling
Updated:  2/7/2018
Baylor College of Medicine
mi
from
Houston, TX
Carotid Plaque Characteristics by MRI in AIM-HIGH (Carotid MRI Substudy)
Carotid Plaque Characteristics by MRI in AIM-HIGH
Status: Enrolling
Updated: 2/7/2018
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials